Esophageal Adenocarcinoma Clinical Trials in Rochester, Minnesota

5 studies are recruiting for esophageal adenocarcinoma in Rochester, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

   The purpose of this study is to learn the best approach to treating patients with known or suspected Barrett's esophagus by comparing endoscopic surveillance to endoscopic eradication therapy. To diagnose and manage Barrett's esophagus and low-grade dysplasia, doctors commonly use procedures called…

   Stage

   Not phased

   Ages

   18 to 89

   Site

   Mayo Clinic, Rochester, Minnesota

   Locations

   30 in total

   Run by

   University of Colorado, Denver

   See if you can join NCT05753748 on ClinicalTrials.gov

2. Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

   The purpose of this research study is to learn about the best approach to sample patients with known or suspected Barrett's esophagus (BE) by comparing the standard Seattle biopsy protocol to sampling using wide area transepithelial sampling (WATS3D). Barrett's esophagus is a common condition that …

   Stage

   Not phased

   Ages

   18 to 89

   Site

   Mayo Clinic, Rochester, Minnesota

   Locations

   14 in total

   Run by

   University of Colorado, Denver

   See if you can join NCT05530343 on ClinicalTrials.gov

3. Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

   This clinical trial evaluates the use of cytosponge, a minimally invasive collection device, for the detection of Barrett's esophagus (BE) in patients undergoing endoscopy. Non-endoscopic swallowable encapsulate sponge cell collection devices combined with markers for BE/esophageal adenocarcinoma (…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Mayo Clinic in Rochester, Rochester, Minnesota

   Locations

   5 in total

   Run by

   Mayo Clinic

   See if you can join NCT06071845 on ClinicalTrials.gov

4. Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

   This research is designed to determine if experimental treatment with AZD5863, a T cell-engaging bispecific antibody that targets Claudin 18.2 (CLDN18.2) and CD3, is safe, tolerable and has anti-cancer activity in patients with advanced solid tumors.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Research Site, Rochester, Minnesota

   Locations

   25 in total

   Run by

   AstraZeneca

   See if you can join NCT06005493 on ClinicalTrials.gov

5. Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

   This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Mayo Clinic Rochester, Rochester, Minnesota

   Locations

   9 in total

   Run by

   Mayo Clinic

   See if you can join NCT03961945 on ClinicalTrials.gov